As of September 18, 2026, ANURAS is trading at ₹1207.7, with a technical stance that shows mixed signals across different timeframes. The daily timeframe indicates a bearish trend, with the price below key moving averages like the 20-day EMA (₹1220.08) and the 50-day EMA (₹1236.08), and the Supertrend indicator at ₹1258.88 suggesting a bearish direction. This is further supported by a daily ADX of 27.43, indicating a trending market, though the negative slope of the EMAs suggests weakening momentum.

In contrast, the weekly timeframe presents a more constructive picture, with the Supertrend at ₹1133.98 indicating a bullish direction and the price trading above this indicator. However, the price is below the 20-day EMA (₹1250.54) and 50-day EMA (₹1218.01) on the weekly chart, suggesting some short-term overhead pressure. The monthly timeframe shows a bearish Supertrend at ₹1509.95, with the price below it, but the price is above the 20-day EMA (₹1130.96) and 20-day SMA (₹1132.61), indicating potential underlying support. The presence of a "Bearish Engulfing Reversal" pattern on the monthly chart and a "Morning Star" on the daily chart highlights conflicting signals and potential for price action.

Nearest support is observed around ₹1200.43, with further levels at ₹1190.87 and ₹1183.43. Resistance is noted at ₹1207.87, followed by ₹1271.41. The stock's current drawdown is -12%, with annualized volatility at 28%, indicating a notable risk level. Recent market activity includes 2 downside events in the last 30 days, suggesting heightened caution.

Anupam Rasayan India Limited announced a series of board meetings and related financial activities. On September 17, 2026, the company's board approved its subsidiary, Mates Visa Consultancy Private Limited (MVCPL), to issue up to ₹300 crore in senior secured unlisted redeemable non-convertible debentures. This financing is secured by a corporate guarantee from the parent company and a pledge of 100% of MVCPL's equity shares. The board also approved a call option agreement for a 15% stake in Purebliss Pharma Solutions Private Limited. Earlier, on September 16, 2026, the company had intimated that a board meeting was scheduled for September 19, 2026, to consider raising funds up to ₹160 crore through the issuance of secured rated unlisted redeemable non-convertible debentures via private placement. Additionally, on September 9, 2026, the company published a newspaper advertisement regarding its 23rd Annual General Meeting (AGM) scheduled for September 30, 2026, to be conducted via video conferencing with e-voting facilities. The Annual Report for the financial year 2025-26 was also dispatched along with the AGM notice.

On September 17, 2026, Anupam Rasayan India Limited announced a significant financing initiative through its wholly-owned subsidiary, Mates Visa Consultancy Private Limited (MVCPL). The board approved MVCPL's issuance of up to ₹300 crore in senior secured unlisted redeemable non-convertible debentures via private placement. To support this, Anupam Rasayan India will provide a corporate guarantee for the full amount and pledge 100% of its equity shares in MVCPL. Additionally, the company approved a call option agreement allowing Purebliss Pharma Solutions Private Limited to purchase Anupam Rasayan India's 15% stake in Purebliss, with that stake also being pledged.

In terms of recent trading activity, the stock closed at ₹1207.7 on September 18, 2026, an increase from its previous close of ₹1181.3. This marks a shift from the prior day's trading.

Anupam Rasayan India Limited's board approved significant financing and strategic actions. On September 17, 2026, the company authorized its subsidiary, Mates Visa Consultancy Private Limited (MVCPL), to issue up to ₹300 crore in senior secured unlisted redeemable non-convertible debentures. To support this, Anupam Rasayan provided a corporate guarantee for the full amount and pledged 100% of its equity shares in MVCPL. Separately, the board approved a call option agreement allowing Purebliss Pharma Solutions Private Limited to buy the company's 15% stake in Purebliss, with that stake also pledged. Earlier, on September 9, 2026, the company completed the acquisition of 2,60,065 equity shares in Tanfac Industries Limited at ₹2,341 per share, for a total consideration of ₹60,88,12,165, via a preferential issue. The company also announced its 23rd Annual General Meeting (AGM) for September 30, 2026, where it will seek approval for a final dividend of ₹1.5 per share for the financial year 2025-26. The record date for this dividend was set as September 18, 2026.

Anupam Rasayan India's recent operating performance shows a mixed trajectory. For the quarter ending June 2026 (Q1 FY27), the company reported Revenue from Operations of ₹654.98 crore, an increase from ₹512.45 crore in the prior year's comparable quarter (Q3 FY26). However, Profit Before Tax for Q1 FY27 was ₹69.68 crore, down from ₹59.95 crore in Q3 FY26, indicating margin pressure. Finance Costs increased to ₹49.19 crore in Q1 FY27 from ₹35.16 crore in Q3 FY26, while Other Expenses also rose to ₹143.03 crore from ₹93.33 crore over the same periods.

Looking at the balance sheet, Borrowings have shown an upward trend, increasing from ₹822 crore in March 2023 to ₹1069 crore in March 2024, and are projected to reach ₹1373 crore by March 2025 and ₹1867 crore by March 2026. This rise in debt is accompanied by an increase in Fixed Assets and CWIP, suggesting ongoing capital expenditure. The company's Cash Flow from Operations has been volatile, with a negative ₹30 crore projected for March 2025, contrasting with a positive ₹59 crore in March 2024. Free Cash Flow has also been negative in recent projections, standing at -₹440 crore for March 2025, down from -₹644 crore in March 2024.

Key monitoring areas include the company's ability to manage its increasing debt levels, improve operating cash flow generation, and translate revenue growth into sustainable profitability. The trend in working capital days, which has fluctuated and is projected to be 160 days by March 2025, also warrants attention.

The company has demonstrated strong growth in both sales and profits over the last five years and on a trailing twelve months (TTM) basis. Sales have compounded at 24% over five years and 52% TTM, while profits have grown at 19% over five years and 42% TTM. This indicates an accelerating growth trajectory. Financially, the company's total assets are projected to increase significantly from ₹5,269 crore in March 2025 to ₹8,013 crore in March 2026, driven by a substantial rise in fixed assets and other assets. Reserves are also expected to grow from ₹2,740 crore to ₹3,188 crore over the same period. Cash flow from operations is anticipated to turn positive, moving from a negative ₹30 crore in March 2025 to a positive ₹334 crore in March 2026, alongside a substantial increase in cash flow from financing activities from ₹223 crore to ₹621 crore. On a weekly technical basis, the supertrend indicator suggests a bullish trend.

The company's financial position shows increasing leverage and negative free cash flow. Borrowings are projected to rise significantly from ₹1,373 crore in March 2025 to ₹1,867 crore in March 2026. Concurrently, free cash flow is expected to remain negative, moving from -₹440 crore in March 2025 to -₹220 crore in March 2026. While fixed assets are increasing, indicating potential investment in growth, this is accompanied by a substantial rise in other liabilities to ₹2,843 crore by March 2026. Technical indicators also suggest a bearish trend, with the daily Supertrend direction noted as bearish and the monthly Supertrend direction also bearish, with a high ADX of 69.73 indicating strong trend momentum.